You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Publishing research using ab26039? Please let us know so that we can cite the reference in this datasheet.

ab26039 has been referenced in 4 publications.

  • Dean JL  et al. Modification of the DNA Damage Response by Therapeutic CDK4/6 Inhibition. J Biol Chem 287:29075-87 (2012). WB ; Human . PubMed: 22733811
  • Slupianek A  et al. BCR/ABL stimulates WRN to promote survival and genomic instability. Cancer Res 71:842-51 (2011). WB ; Mouse . PubMed: 21123451
  • Salton M  et al. Involvement of matrin 3 and SFPQ/NONO in the DNA damage response. Cell Cycle 9: (2010). PubMed: 20421735
  • Chen X  et al. Rational design of human DNA ligase inhibitors that target cellular DNA replication and repair. Cancer Res 68:3169-77 (2008). IP ; Human . PubMed: 18451142

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"